InvestorsHub Logo

Number sleven

07/25/22 4:56 PM

#384288 RE: ggwpq #384287

ggwp, I can't believe that it is an error.
Sleven,

rosemountbomber

07/25/22 5:46 PM

#384291 RE: ggwpq #384287

Secondary cardiovascular prevention can be defined as any strategy aimed at reducing the probability of a recurrent cardiovascular event in patients with known atherosclerotic CVD, including coronary artery disease, cerebrovascular artery disease, peripheral artery disease, and atherosclerotic aortic disease.



https://world-heart-federation.org/cvd-roadmaps/wp-content/uploads/sites/3/2021/04/WHF_Roadmap_Secondary_Prevention.pdf

CaptBeer

07/25/22 5:49 PM

#384292 RE: ggwpq #384287

Does NICE UK indication include PAD patients?
Interesting observation ggwpq. If true, that adds significant numbers to the POP (Potential Patient Population). I ran some quick numbers for PAD Incidence/Prevalence (2019) in England, Northern Ireland, Scotland and Wales. It turns out that PAD is fairly prevalent in these 4 countries.